Franchise Lead - Hematology

Job description

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us. Bristol Myers Squibb es un empleador que brinda igualdad de oportunidades. Las personas que apliquen para cualquier vacante, y que estén calificadas para la misma recibirán consideración para el empleo sin distinción de raza, color, religión, sexo, orientación sexual, identidad de género, nacionalidad, edad, discapacidad, condición de veterano protegido, embarazo, ciudadanía, estado civil, expresión de género, información genética, afiliación política o cualquier otra característica protegida por la ley. The Franchise Lead, Hematology leads the execution of the strategy and commercial plan for the BMS Hematology portfolio in Mexico, delivering the franchise's revenue targets and launch objectives under the direction of the Head of Commercial. This is a people-leadership role that manages a Brand Lead and a District Manager while serving as the Decision Maker for the CELMoDs Unified Brand Plan (UBP), the franchise's central launch priority. The role develops and executes brand and franchise plans across in-line and pipeline assets, coordinates launch readiness for the 2027–2029 hematology wave (Iberdomide, Mezigdomide, Golcadomide; Breyanzi CAR-T), and sustains the in-line Reblozyl trajectory. It integrates asset-level plans into a coherent franchise recommendation and submits it to the Head of Commercial. Key Responsibilities A. Franchise Planning & Execution Execute the annual franchise strategic and commercial plan (per quarter and per year) to meet the Hematology revenue and launch commitments, in alignment with the direction set by the Head of Commercial. Support portfolio prioritization and manage resource allocation across in-line and pipeline assets within the approved budget. Prepare business reviews, brand plans, and business cases with cross-functional teams for review. B. CELMoDs Brand Strategy & UBP — Decision Maker Develop and execute the UBP (8 Strategic Choices) for CELMoDs Mexico as the Decision Maker (D) under the DAI model. Deliver P1–P3 UBP Updates, applying the 7 Key Business Questions to adapt the plan to market learnings. Manage the 360° Brand Plan for CELMoDs — pre-launch market shaping, launch, execution, and post-launch optimization across public and private sectors. Integrate CELMoDs and Reblozyl plans into a coherent franchise recommendation for the Head of Commercial's approval. C. Launch Execution Lead and coordinate launch readiness and execution for CELMoDs (Iberdomide MM, best-case Q1 2027; Mezigdomide 2028; Golcadomide 2029) and Breyanzi CAR-T (2028 assumption). Coordinate immersion workshops, launch execution, and stakeholder communication across MM and Lymphoma. D. People Leadership & Team Development Lead, coach, and develop the Reblozyl Brand Lead and the Hematology District Manager (who leads the TAS field team). Set performance objectives, drive development plans, and support talent, succession, and capability building. Foster a high-performance, AI-enabled, patient-centric culture. E. Commercial Planning, Forecasting & Budget Develop scenario planning and production forecasts for the franchise. Track performance via business reviews and KPIs, and course-correct in line with UBP Updates. Define project budgets, manage monthly accruals and reconciliation, and ensure franchise expenses stay within the approved budget; provide CIP inputs and resource recommendations. F. Access, Institutional & Patient Journey Identify key milestones across sectors: Private, decentralized, and centralized institutions (IMSS/Torre de Control, ISSSTE, IMSS-Bienestar). Partner with HEOR on price strategy; support access execution across fragmented public/private payers. Support execution across the full patient journey, including digital/omnichannel solutions. G. Matrix Leadership & Cross-Functional Coordination Coordinate projects and initiatives across Medical, Market Access, and commercial operations (DAI Advisors) without direct authority. Partner with LATAM Launch Excellence and Global 3M partners; engage KOLs per sector. H. Managing Up & Stakeholder Engagement Manage up to the Head of Commercial on launch readiness, opportunities, tradeoffs, and resource needs. Translate franchise choices into clear recommendations for the Head of Commercial. I. AI-Led Commercialization Champion local adoption of SAMai, UBP Accelerator, and AI-enabled decision-making across the franchise team. Skills & Proficiency Requirements Skill Pillar Required Proficiency Scientific Agility Proficient — hematology / MM / Lymphoma / CELMoD MoA fluency Insight & Analytical Fluency Expert Access Acumen Proficient — elevated given Mexico public/private complexity Strategic Thinking & Articulation Expert Data-Driven Customer Experience Proficient/Expert Financial & Business Acumen Proficient — budget, accruals, ROI (P&L ownership at Head of Commercial) People Leadership Proficient/Expert — team development, coaching, performance management Qualifications Required: Bachelor's degree in Life Sciences, Business, Pharmacy, Medicine, or related field; MBA/advanced degree preferred. 7+ years progressive pharmaceutical commercial/marketing experience; 3+ years in Brand/Franchise Management. Hematology experience preferred; Oncology experience desired. Demonstrated experience leading teams. Demonstrated launch experience in Mexico (hematology/oncology preferred). Working understanding of Mexican public sector (IMSS, ISSSTE, IMSS-Bienestar, tenders) and private-sector dynamics. Ability to lead and influence in a matrix environment without direct authority. Strong commercial acumen: forecasting, GTM planning, performance management, budget accuracy. Fluent Spanish and professional working English #LI-Hybrid If you come across a role that intrigues you but doesn’t perfectly line up with your resume, we encourage you to apply anyway. You could be one step away from work that will transform your life and career. Uniquely Interesting Work, Life-changing Careers With a single vision as inspiring as “Transforming patients’ lives through science™ ”, every BMS employee plays an integral role in work that goes far beyond ordinary. Each of us is empowered to apply our individual talents and unique perspectives in a supportive culture, promoting global participation in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues. On-site Protocol BMS has an occupancy structure that determines where an employee is required to conduct their work. This structure includes site-essential, site-by-design, field-based and remote-by-design jobs. The occupancy type that you are assigned is determined by the nature and responsibilities of your role: Site-essential roles require 100% of shifts onsite at your assigned facility. Site-by-design roles may be eligible for a hybrid work model with at least 50% onsite at your assigned facility. For these roles, onsite presence is considered an essential job function and is critical to collaboration, innovation, productivity, and a p